R. Or

1.4k total citations
48 papers, 1.0k citations indexed

About

R. Or is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, R. Or has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 15 papers in Immunology and 11 papers in Oncology. Recurrent topics in R. Or's work include Hematopoietic Stem Cell Transplantation (21 papers), Immune Cell Function and Interaction (10 papers) and Polyomavirus and related diseases (5 papers). R. Or is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Immune Cell Function and Interaction (10 papers) and Polyomavirus and related diseases (5 papers). R. Or collaborates with scholars based in Israel, United States and United Kingdom. R. Or's co-authors include Aliza Ackerstein, E Naparstek, Joseph Kapelushnik, Chaim Brautbar, A Nagler, S Samuel, S Slavin, Arnon Nagler, S Slavin and Elizabeth Naparstek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

R. Or

48 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Or Israel 16 698 410 267 130 128 48 1.0k
Emmanuel Thomas United States 10 893 1.3× 423 1.0× 222 0.8× 186 1.4× 130 1.0× 12 1.1k
GB Vogelsang United States 14 632 0.9× 272 0.7× 175 0.7× 111 0.9× 72 0.6× 22 830
Carmen Martín Spain 19 646 0.9× 252 0.6× 246 0.9× 173 1.3× 153 1.2× 47 916
PJ Martin United States 13 1.2k 1.7× 748 1.8× 268 1.0× 154 1.2× 123 1.0× 20 1.5k
J. Gajewski United States 14 687 1.0× 399 1.0× 273 1.0× 84 0.6× 224 1.8× 17 1.0k
Dawn Jones United States 17 758 1.1× 744 1.8× 191 0.7× 134 1.0× 131 1.0× 28 1.4k
J M Vossen Netherlands 12 546 0.8× 332 0.8× 227 0.9× 125 1.0× 121 0.9× 32 906
ED Thomas United States 14 634 0.9× 229 0.6× 177 0.7× 155 1.2× 63 0.5× 28 841
Robert Bélanger Canada 16 551 0.8× 308 0.8× 164 0.6× 62 0.5× 189 1.5× 42 906
Deeg Hj United States 15 609 0.9× 231 0.6× 208 0.8× 133 1.0× 62 0.5× 46 893

Countries citing papers authored by R. Or

Since Specialization
Citations

This map shows the geographic impact of R. Or's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Or with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Or more than expected).

Fields of papers citing papers by R. Or

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Or. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Or. The network helps show where R. Or may publish in the future.

Co-authorship network of co-authors of R. Or

This figure shows the co-authorship network connecting the top 25 collaborators of R. Or. A scholar is included among the top collaborators of R. Or based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Or. R. Or is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kristt, Don, Benjamin Gesundheit, Jerry Stein, et al.. (2009). Quantitative monitoring of multi-donor chimerism: a systematic, validated framework for routine analysis. Bone Marrow Transplantation. 45(1). 137–147. 12 indexed citations
2.
Rapaport, David, et al.. (2002). Antiviral prophylaxis may prevent human herpesvirus‐6 reactivation in bone marrow transplant recipients. Transplant Infectious Disease. 4(1). 10–16. 47 indexed citations
3.
Shalit, Meir, A. Amar, & R. Or. (2002). Allergy development after bone marrow transplantation from a non‐atopic donor. Clinical & Experimental Allergy. 32(12). 1699–1701. 13 indexed citations
4.
Sviri, Sigal, et al.. (2001). Plasmapheresis for Thrombotic Thrombocytopenic Purpura following Bone Marrow Transplantation. Acta Haematologica. 105(3). 156–158. 6 indexed citations
5.
Peylan‐Ramu, Nili, Gabriel Cividalli, G. Váradi, et al.. (1999). The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases. Bone Marrow Transplantation. 23(9). 861–865. 14 indexed citations
6.
Or, R., Aliza Ackerstein, Arnon Nagler, et al.. (1998). Allogeneic Cell-Mediated and Cytokine-Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation. Journal of Immunotherapy. 21(6). 447–453. 26 indexed citations
7.
Ben-Yehuda, A, et al.. (1997). Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice. Bone Marrow Transplantation. 19(6). 539–543. 15 indexed citations
8.
Toren, Amos, et al.. (1997). Impaired liver function tests in patients treated with antithymocyte globulin: Implication for liver transplantation. Medical Oncology. 14(3-4). 125–129. 3 indexed citations
9.
Meirow, Dror, Alana A. Lewin, R. Or, et al.. (1997). P-261 Ovarian failure post-chemotherapy in young cancer patients-risk assessment indicate the need for intervention. Fertility and Sterility. 68. S218–S218. 8 indexed citations
10.
Toren, Amos, et al.. (1996). Normalization of serum lactic dehydrogenase in β-thalassemia patients following bone marrow transplantation. American Journal of Hematology. 51(2). 166–167. 1 indexed citations
11.
Nagler, Arnon, Yaron Ilan, G. Váradi, Joseph Kapelushnik, & R. Or. (1996). In vivo CAMPATH-1 followed by T cell-depleted bone marrow transplantation: a potential new mode of therapy for hepatitis-associated severe aplastic anemia (SAA).. PubMed. 18(2). 475–8. 7 indexed citations
12.
13.
Toren, Amos, Daniela Novick, R. Or, et al.. (1996). SOLUBLE INTERLEUKIN-6 RECEPTORS IN HEMATOLOGY PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION1. Transplantation. 62(1). 138–142. 15 indexed citations
14.
Chaushu, Gavriel, et al.. (1995). A longitudinal follow-up of salivary secretion in bone marrow transplant patients. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 79(2). 164–169. 39 indexed citations
15.
Amiel, Aliza, et al.. (1994). Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization. Cancer Genetics and Cytogenetics. 76(1). 59–64. 24 indexed citations
16.
Mehta, Jay, et al.. (1994). Cyclophosphamide-induced cardiomyopathy during bone marrow transplantation for severe aplastic anemia.. PubMed. 42(2). 159–60. 1 indexed citations
17.
Naparstek, E, R. Or, Arnon Nagler, et al.. (1993). ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES. Experimental Hematology. 21. 1061–1061. 3 indexed citations
18.
Slavin, Shimon, R. Or, P Drakos, et al.. (1992). Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT).. PubMed. 6 Suppl 4. 164–6. 17 indexed citations
19.
Slavin, Shimon, Aliza Ackerstein, Lola Weiss, et al.. (1992). Immunotherapy of Minimal Residual Disease by Immunocompetent Lymphocytes and Their Activation by Cytokines. Cancer Investigation. 10(3). 221–227. 42 indexed citations
20.
Renz, H., R. Or, Joanne Domenico, Donald Y.M. Leung, & Erwin W. Gelfand. (1992). Reciprocal regulatory effects of IL-4 on cell growth and immunoglobulin production in Ig-secreting human B-cell lines. Clinical Immunology and Immunopathology. 64(3). 233–241. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Thomas Breakdown of academic impact, for papers by GB Vogelsang Breakdown of academic impact, for papers by Carmen Martín Breakdown of academic impact, for papers by PJ Martin Breakdown of academic impact, for papers by J. Gajewski Breakdown of academic impact, for papers by Dawn Jones Breakdown of academic impact, for papers by J M Vossen Breakdown of academic impact, for papers by ED Thomas Breakdown of academic impact, for papers by Robert Bélanger Breakdown of academic impact, for papers by Deeg Hj
Rankless by CCL
2026